(2005). Falezza G: Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy. Diabet Med
(2008). Relation between fasting glucose and retinopathy for diagnosis of diabetes: three populationbased cross-sectional studies. Lancet
(2001). Shahinfar S: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
(2005). Stehouwer CD: Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease
(2004). Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int